Related Experiment Video

Updated: Aug 5, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic Virotherapy, Long Stalled, Nears Second Approval

    Cancer Discovery
    |July 27, 2026
    PubMed

    Insights

    Oncolytic virus therapy for cancer has seen limited advancement since T-VEC

    Area of Science:

    • Oncology
    • Virology
    • Biotechnology

    Background:

    • The field of oncolytic virus therapy has progressed slowly since the initial approval of T-VEC.
    • Challenges include flawed trial designs, suboptimal drug combinations, tumor defenses like hypoxia, and difficulties with intravenous delivery.

    Purpose of the Study:

    • To review the current state and challenges in oncolytic virus therapy.
    • To identify emerging trends and potential breakthroughs in the field.

    Main Methods:

    • Analysis of the current landscape of oncolytic virus development.
    • Review of recent research on novel delivery methods and combination strategies.
    • Examination of upcoming oncolytic virus candidates and their clinical trial status.

    Main Results:

    • RP1, a herpesvirus candidate, faces regulatory review but still represents a locally injected therapy.
    • Despite obstacles, new approaches like sequencing, neoadjuvant treatments, and a bladder cancer virus show promise.
    • The field is showing signs of renewed momentum.

    Conclusions:

    • Significant hurdles remain in oncolytic virus therapy, limiting its widespread application.
    • Emerging strategies and a potential new approval suggest a potential resurgence in the field's advancement.

    More Related Videos

    Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

    Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

    Published on: April 15, 2016

    Related Concept Videos

    FDA Approved Drugs: Changes to Approved Drugs01:26

    FDA Approved Drugs: Changes to Approved Drugs

    Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Drug Administration and Therapy Phases: Overview01:26

    Drug Administration and Therapy Phases: Overview

    Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
    The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
    The pharmacokinetic phase...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    Prescription, Nonprescription and Orphan Drugs01:02

    Prescription, Nonprescription and Orphan Drugs

    Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
    The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...